Phase II trial of abraxane administered on a weekly schedule in combination with bevacizumab in metastatic breast cancer

Trial Profile

Phase II trial of abraxane administered on a weekly schedule in combination with bevacizumab in metastatic breast cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Oct 2007

At a glance

  • Drugs Bevacizumab (Primary) ; Paclitaxel (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Oct 2007 Status changed from recruiting to in progress.
    • 03 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top